To identify factors downstream of PERK specifically upregulated in human breast cancers, we compared PERK pathway gene expression between a large cohort of breast cancers (n = 1093) and normal breast tissues (n = 112) (TCGA, breast cancer data set). Here, EIF2AK3 is linked to breast cancer.